$ALOT
AstroNova, Inc.

2013 Q3 Form 10-Q Financial Statement

#000119312513360867 Filed on September 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q3
Revenue $17.19M $14.66M
YoY Change 17.26% -27.91%
Cost Of Revenue $10.27M $9.106M
YoY Change 12.79% -26.74%
Gross Profit $6.923M $5.557M
YoY Change 24.58% -29.66%
Gross Profit Margin 40.26% 37.9%
Selling, General & Admin $4.762M $4.108M
YoY Change 15.92% -25.17%
% of Gross Profit 68.79% 73.92%
Research & Development $1.274M $885.0K
YoY Change 43.95% -25.63%
% of Gross Profit 18.4% 15.93%
Depreciation & Amortization $330.0K $350.0K
YoY Change -5.71% -14.63%
% of Gross Profit 4.77% 6.3%
Operating Expenses $6.036M $4.993M
YoY Change 20.89% -25.25%
Operating Profit $887.0K $564.0K
YoY Change 57.27% -53.77%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$25.00K -$89.00K
YoY Change -71.91% -129.67%
Pretax Income $862.0K $475.0K
YoY Change 81.47% -68.75%
Income Tax $331.0K $187.0K
% Of Pretax Income 38.4% 39.37%
Net Earnings $696.0K $987.0K
YoY Change -29.48% -6.0%
Net Earnings / Revenue 4.05% 6.73%
Basic Earnings Per Share $0.09 $0.13
Diluted Earnings Per Share $0.09 $0.13
COMMON SHARES
Basic Shares Outstanding 7.458M shares 7.439M shares
Diluted Shares Outstanding 7.655M shares 7.491M shares

Balance Sheet

Concept 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.60M $22.50M
YoY Change 44.89% 11.39%
Cash & Equivalents $12.18M $11.15M
Short-Term Investments $20.40M $11.40M
Other Short-Term Assets $11.10M $3.400M
YoY Change 226.47% -12.82%
Inventory $12.51M $13.90M
Prepaid Expenses
Receivables $9.674M $11.60M
Other Receivables $500.0K $300.0K
Total Short-Term Assets $66.47M $51.70M
YoY Change 28.58% 2.38%
LONG-TERM ASSETS
Property, Plant & Equipment $7.490M $10.80M
YoY Change -30.65% -12.9%
Goodwill $795.0K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K
YoY Change 0.0% 0.0%
Total Long-Term Assets $1.462M $14.10M
YoY Change -89.63% -7.24%
TOTAL ASSETS
Total Short-Term Assets $66.47M $51.70M
Total Long-Term Assets $1.462M $14.10M
Total Assets $75.43M $65.80M
YoY Change 14.63% 0.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.289M $2.100M
YoY Change 9.0% -4.55%
Accrued Expenses $6.000M $4.000M
YoY Change 50.0% -4.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.24M $6.800M
YoY Change 50.54% -8.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.300M $900.0K
YoY Change 44.44% -18.18%
Total Long-Term Liabilities $1.300M $900.0K
YoY Change 44.44% -18.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.24M $6.800M
Total Long-Term Liabilities $1.300M $900.0K
Total Liabilities $11.82M $9.400M
YoY Change 25.7% -11.32%
SHAREHOLDERS EQUITY
Retained Earnings $35.29M
YoY Change
Common Stock $457.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $11.72M
YoY Change
Treasury Stock Shares 1.668M shares
Shareholders Equity $63.61M $56.40M
YoY Change
Total Liabilities & Shareholders Equity $75.43M $65.80M
YoY Change 14.63% 0.15%

Cashflow Statement

Concept 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $696.0K $987.0K
YoY Change -29.48% -6.0%
Depreciation, Depletion And Amortization $330.0K $350.0K
YoY Change -5.71% -14.63%
Cash From Operating Activities $780.0K $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures -$260.0K -$130.0K
YoY Change 100.0% -31.58%
Acquisitions
YoY Change
Other Investing Activities -$110.0K $920.0K
YoY Change -111.96% -58.74%
Cash From Investing Activities -$360.0K $790.0K
YoY Change -145.57% -61.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -430.0K -500.0K
YoY Change -14.0% 35.14%
NET CHANGE
Cash From Operating Activities 780.0K 0.000
Cash From Investing Activities -360.0K 790.0K
Cash From Financing Activities -430.0K -500.0K
Net Change In Cash -10.00K 290.0K
YoY Change -103.45% -78.68%
FREE CASH FLOW
Cash From Operating Activities $780.0K $0.00
Capital Expenditures -$260.0K -$130.0K
Free Cash Flow $1.040M $130.0K
YoY Change 700.0% -208.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11704000
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7465011 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11150000
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
690035 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9132899 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
126046 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.64
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
877183 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.61
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1668225 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
8.99
CY2013Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1311000
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26682000
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3768000
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
39597000
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2289000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10237000
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16000
CY2013Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
939000
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2211000
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
63610000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
35292000
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
413000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
457000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
75426000
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
268000
CY2013Q3 us-gaap Liabilities
Liabilities
11816000
CY2013Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1556000
CY2013Q3 us-gaap Assets Current
AssetsCurrent
66474000
CY2013Q3 us-gaap Goodwill
Goodwill
795000
CY2013Q3 us-gaap Financial Instruments Owned State And Municipal Government Obligations At Fair Value
FinancialInstrumentsOwnedStateAndMunicipalGovernmentObligationsAtFairValue
20400000
CY2013Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
20400000
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1800000
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
837000
CY2013Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
569000
CY2013Q3 us-gaap Assets
Assets
75426000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12183000
CY2013Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
6850000
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9674000
CY2013Q3 us-gaap Inventory Net
InventoryNet
12505000
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34172000
CY2013Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
4161000
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2011494
CY2013Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1462000
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1323000
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2522901
CY2013Q3 us-gaap Other Assets
OtherAssets
98000
CY2013Q3 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
2016000
CY2013Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
250000
CY2013Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
27201000
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1862000
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
11720000
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4818000
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7490000
CY2013Q3 alot Money Market Funds At Fair Value
MoneyMarketFundsAtFairValue
6801000
CY2013Q3 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
300000
CY2013Q3 alot Proceeds From Discontinued Operations Held In Escrow
ProceedsFromDiscontinuedOperationsHeldInEscrow
1800000
CY2013Q3 alot Product Replacement Reserve
ProductReplacementReserve
598000
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9031756 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
96900 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.46
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
916612 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2013Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1663214 shares
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
8.10
CY2013Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1289000
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26098000
CY2013Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3164000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38786000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1938000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
14219000
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
173000
CY2013Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
941000
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3176000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
63837000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
36092000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
271000
CY2013Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4169000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
452000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79557000
CY2013Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
212000
CY2013Q1 us-gaap Liabilities
Liabilities
15720000
CY2013Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1501000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
70122000
CY2013Q1 us-gaap Goodwill
Goodwill
795000
CY2013Q1 us-gaap Financial Instruments Owned State And Municipal Government Obligations At Fair Value
FinancialInstrumentsOwnedStateAndMunicipalGovernmentObligationsAtFairValue
8509000
CY2013Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
8509000
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1800000
CY2013Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
591000
CY2013Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
756000
CY2013Q1 us-gaap Assets
Assets
79557000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30999000
CY2013Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
6654000
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9376000
CY2013Q1 us-gaap Inventory Net
InventoryNet
11179000
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33886000
CY2013Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
3131000
CY2013Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
1647000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
696000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1624000
CY2013Q1 us-gaap Other Assets
OtherAssets
96000
CY2013Q1 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
2016000
CY2013Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
250000
CY2013Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
17293000
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1866000
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
11666000
CY2013Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3934000
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7788000
CY2013Q1 alot Money Market Funds At Fair Value
MoneyMarketFundsAtFairValue
8784000
CY2013Q1 alot Line Of Credit Receivable Current
LineOfCreditReceivableCurrent
300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7488985 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.394 pure
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
56827 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.035 pure
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-102000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1105000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.12
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7432158 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.13
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.13
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.11
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
605844 shares
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
8997000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1566000
us-gaap Gross Profit
GrossProfit
11056000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
977000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
890000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
769000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
7676000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1041000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
977000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
358000
us-gaap Operating Income Loss
OperatingIncomeLoss
992000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
847000
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
4615000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-251000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-223000
us-gaap Net Income Loss
NetIncomeLoss
1824000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-183000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-258000
us-gaap Sales Revenue Net
SalesRevenueNet
29000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
318000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
41000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1469000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2151000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1000000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
17944000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
125000
us-gaap Share Based Compensation
ShareBasedCompensation
125000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-554000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6043000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-221000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
595000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-659000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1870000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
687000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
7635000
dei Entity Central Index Key
EntityCentralIndexKey
0000008146
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Operating Expenses
OperatingExpenses
10064000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000
alot Income Tax Expense
IncomeTaxExpense
312000
alot Deferred Income Tax Benefit
DeferredIncomeTaxBenefit
111000
alot Income Tax Benefit Favorable Resolution Of Previously Uncertain Tax Position
IncomeTaxBenefitFavorableResolutionOfPreviouslyUncertainTaxPosition
269000
alot Line Of Credit Issuance
LineOfCreditIssuance
300000
dei Entity Registrant Name
EntityRegistrantName
ASTRO MED INC /NEW/
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-08-03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
57544 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.008 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7616818 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.383 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
187565 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(1) Overview</b></font></p> <p style="PADDING-BOTTOM: 0px; MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Headquartered in West Warwick, Rhode Island, Astro-Med Inc. designs, develops, manufactures and distributes a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our branch offices in Canada and Europe as well as with independent dealers and representatives. Astro-Med, Inc. products are sold under the brand names Astro-Med&#xA0;<font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">&#xAE;</sup></font> Test&#xA0;&amp; Measurement and QuickLabel <font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">&#xAE;</sup></font> Systems and are employed around the world in a wide range of aerospace, automotive, communications, chemical, food and beverage, military, industrial, and packaging applications.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">Unless otherwise indicated, references to &#x201C;Astro-Med,&#x201D; the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; &#x201C;our,&#x201D; and &#x201C;us&#x201D; in this Quarterly Report on Form&#xA0;10-Q refer to Astro-Med, Inc. and its consolidated subsidiaries.</font></p> </div>
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
8.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Purchase Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
0.15 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.54
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.026 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5999000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
564000
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
288000
CY2012Q3 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
2743000
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-302000
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-89000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
987000
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-304000
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
14663000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56800 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.14
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7429253 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
21424 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.02
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y4M24D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
74805 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.02
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
173300 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
28398 shares
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
3716000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
58000
us-gaap Gross Profit
GrossProfit
12027000
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
155000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
103000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4751000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
17835000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1047000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
155000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
100000
us-gaap Operating Income Loss
OperatingIncomeLoss
165000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
92000
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
378000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-193000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
535000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-62000
us-gaap Net Income Loss
NetIncomeLoss
247000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2118000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-189000
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-189000
us-gaap Sales Revenue Net
SalesRevenueNet
32679000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
374000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
489000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
188000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2521000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-558000
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
us-gaap Cost Of Goods Sold
CostOfGoodsSold
19980000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
273000
us-gaap Share Based Compensation
ShareBasedCompensation
273000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18816000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6954000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-4649000
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
87000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12259000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2387000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
636000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5950000
us-gaap Operating Expenses
OperatingExpenses
11862000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000
alot Escrow Deposit Period
EscrowDepositPeriod
P12M
alot Deferred Income Tax Benefit
DeferredIncomeTaxBenefit
59000
alot Loan Receivable Interest Rate Stated Percentage
LoanReceivableInterestRateStatedPercentage
0.06 pure
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
699000
alot Projected Effective Tax Rate Current Year
ProjectedEffectiveTaxRateCurrentYear
0.107 pure
alot Projected Effective Tax Rate One Year Before
ProjectedEffectiveTaxRateOneYearBefore
0.049 pure
alot Transition Services Period Maximum
TransitionServicesPeriodMaximum
P12M
alot Transition Services Period Minimum
TransitionServicesPeriodMinimum
P9M
alot Product Replacement Related Costs
ProductReplacementRelatedCosts
672000
alot Disposal Restriction As Percentage Of Restricted Stock Units
DisposalRestrictionAsPercentageOfRestrictedStockUnits
0.50 pure
alot Payable Period For Interest On Note Receivable
PayablePeriodForInterestOnNoteReceivable
16 Installment
alot Short Term Investment Securities Original Maturity Greater Than Ninety Days
ShortTermInvestmentSecuritiesOriginalMaturityGreaterThanNinetyDays
P90D
alot Loan Receivable Date Considered For Interest Payments
LoanReceivableDateConsideredForInterestPayments
2013-01-30
CY2012 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
1000000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M24D
CY2013 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
18600000
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.09
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2012Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7491160 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
51935 shares
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.01
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.04
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7439225 shares
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.09
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.09
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.04
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
605844 shares
CY2012Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
4909000
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
683000
CY2012Q3 us-gaap Gross Profit
GrossProfit
5557000
CY2012Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
699000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
475000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
331000
CY2013Q3 alot Projected Effective Tax Rate Current Year
ProjectedEffectiveTaxRateCurrentYear
0.384 pure
CY2013Q3 alot Projected Effective Tax Rate One Year Before
ProjectedEffectiveTaxRateOneYearBefore
0.395 pure
CY2013Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
1965000
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1115000
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
9106000
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.79
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.07
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7457652 shares
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.02
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.02
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.07
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
173300 shares
CY2012Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
78000
CY2012Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2993000
CY2012Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
415000
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
885000
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
4993000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
187000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7654984 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
197332 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
662000
CY2013Q3 us-gaap Gross Profit
GrossProfit
6923000
CY2013Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
165000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
862000
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
165000
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
887000
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
531000
CY2013Q3 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
327000
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-39000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
696000
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-34000
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
17194000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1380000
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
10271000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
113000
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3382000
CY2013Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
94000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1274000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
6036000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.79

Files In Submission

Name View Source Status
0001193125-13-360867-index-headers.html Edgar Link pending
0001193125-13-360867-index.html Edgar Link pending
0001193125-13-360867.txt Edgar Link pending
0001193125-13-360867-xbrl.zip Edgar Link pending
alot-20130803.xml Edgar Link completed
alot-20130803.xsd Edgar Link pending
alot-20130803_cal.xml Edgar Link unprocessable
alot-20130803_def.xml Edgar Link unprocessable
alot-20130803_lab.xml Edgar Link unprocessable
alot-20130803_pre.xml Edgar Link unprocessable
d555585d10q.htm Edgar Link pending
d555585dex311.htm Edgar Link pending
d555585dex312.htm Edgar Link pending
d555585dex321.htm Edgar Link pending
d555585dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending